Upgrades/Downgrades
Updated: 19-Aug-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Moderna | MRNA | BofA Securities | Underperform » Neutral | ||
| Suncor Energy | SU | Morgan Stanley | Equal-Weight » Overweight | ||
| Moderna | MRNA | William Blair | Mkt Perform » Outperform | ||
| TWFG, Inc. | TWFG | Morgan Stanley | Equal-Weight » Overweight | $30 | |
| Neptune Insurance Holdings | NP | Morgan Stanley | Equal-Weight » Overweight | $36 | |
| Honeywell Aerospace | HONA | Morgan Stanley | Equal-Weight » Overweight | $205 | |
| Fabrinet | FN | Fox Advisors | Equal Weight » Overweight | ||
| Dominion Energy | D | TD Cowen | Hold » Buy | $80 | |
| Dollar Tree | DLTR | Jefferies | Underperform » Hold | $135 | |
| Ciena | CIEN | Northland Capital | Market Perform » Outperform | $500 | |
| APA Corp. | APA | Argus | Hold » Buy | $48 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Infosys | INFY | CLSA | Outperform » Hold | ||
| Wipro | WIT | CLSA | Hold » Underperform | ||
| Bank of Montreal | BMO | CIBC | Sector Outperform » Neutral | ||
| Diamondback Energy | FANG | Morgan Stanley | Overweight » Equal-Weight | $216 | |
| Pershing Square, Inc. | PS | Citigroup | Buy » Neutral | $45 | |
| Pediatrix Medical Group | MD | Jefferies | Buy » Hold | $28 | |
| Mereo BioPharma | MREO | JP Morgan | Neutral » Underweight | ||
| Klarna Group plc | KLAR | JP Morgan | Overweight » Neutral | $18 | |
| Core Natural Resources | CNR | UBS | Buy » Neutral | $105 | |
| Cogent Communications | CCOI | JP Morgan | Neutral » Underweight | $9 | |
| CME Group | CME | Deutsche Bank | Buy » Hold | $270 | |
| Baidu | BIDU | Morgan Stanley | Equal-Weight » Underweight | $80 | |
| DeFi Technologies | DEFT | Maxim Group | Buy » Hold | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| ResMed | RMD | Rothschild & Co Redburn | Neutral | $230 | |
| Prime Medicine | PRME | BMO Capital Markets | Outperform | $9 | |
| Perspective Therapeutics | CATX | BMO Capital Markets | Outperform | $11 | |
| McKesson | MCK | RBC Capital Mkts | Sector Perform | $845 | |
| KE Holdings | BEKE | CLSA | Outperform | $23.80 | |
| Ionis Pharma | IONS | BMO Capital Markets | Market Perform | $60 | |
| Healthcare Services Group | HCSG | Oppenheimer | Outperform | $28 | |
| Exelixis | EXEL | BMO Capital Markets | Market Perform | $54 | |
| DarioHealth | DRIO | Alliance Global Partners | Buy | $12 | |
| Cencora | COR | RBC Capital Mkts | Sector Perform | $330 | |
| Cardinal Health | CAH | RBC Capital Mkts | Outperform | $276 | |
| BioMarin Pharmaceutical | BMRN | BMO Capital Markets | Outperform | $98 | |
| Bicara Therapeutics | BCAX | BMO Capital Markets | Outperform | $35 | |
| Ascendis Pharma | ASND | BMO Capital Markets | Outperform | $319 | |
| Alnylam Pharma | ALNY | BMO Capital Markets | Outperform | $318 | |
| Aktis Oncology | AKTS | Wedbush | Outperform | $35 | |
| Aktis Oncology | AKTS | BMO Capital Markets | Outperform | $37 | |
| AgomAb Therapeutics NV | AGMB | Cantor Fitzgerald | Overweight | ||
| Aflac | AFL | Wolfe Research | Underperform | ||
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Zoom Communications | ZM | BofA Securities | Buy | $130 | |
| Safehold | SAFE | Raymond James | Mkt Perform | ||
| Cricut | CRCT | Goldman | Sell | $4.50 | |
| Corsair Gaming | CRSR | Goldman | Sell | $11 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |